Bank of Montreal’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $885K | Buy |
108,725
+92,288
| +561% | +$837K | ﹤0.01% | 2099 |
|
|
2025
Q4 | $110K | Buy |
16,437
+2,896
| +21% | +$21.8K | ﹤0.01% | 3021 |
|
|
2025
Q3 | $117K | Sell |
13,541
-890
| -6% | -$6.93K | ﹤0.01% | 2928 |
|
|
2025
Q2 | $90.9K | Buy |
14,431
+162
| +1% | +$1.07K | ﹤0.01% | 3007 |
|
|
2025
Q1 | $91.5K | Sell |
14,269
-46
| -0.3% | -$380 | ﹤0.01% | 2939 |
|
|
2024
Q4 | $115K | Sell |
14,315
-2,440,010
| -99% | -$23.5M | ﹤0.01% | 2917 |
|
|
2024
Q3 | $32.6M | Buy |
2,454,325
+418,927
| +21% | +$5.41M | 0.01% | 606 |
|
|
2024
Q2 | $29M | Buy |
2,035,398
+1,375,047
| +208% | +$13.8M | 0.01% | 636 |
|
|
2024
Q1 | $5.07M | Sell |
660,351
-195,406
| -23% | -$906K | ﹤0.01% | 1220 |
|
|
2023
Q4 | $6.57M | Buy |
+855,757
| New | +$5.24M | ﹤0.01% | 1172 |
|
|
2023
Q3 | – | Sell |
-18,131
| Closed | -$148K | – | 4096 |
|
|
2023
Q2 | $148K | Buy |
18,131
+413
| +2% | +$3.25K | ﹤0.01% | 3332 |
|
|
2023
Q1 | $124K | Buy |
+17,718
| New | +$163K | ﹤0.01% | 3186 |
|
|
2022
Q4 | – | Sell |
-135,118
| Closed | -$2.63K | – | 4197 |
|
|
2022
Q3 | $2.63K | Buy |
135,118
+1,830
| +1% | +$79.3K | ﹤0.01% | 1684 |
|
|
2022
Q2 | $7.07K | Buy |
133,288
+124,666
| +1,446% | +$6.46M | ﹤0.01% | 1224 |
|
|
2022
Q1 | $685K | Sell |
8,622
-22,208
| -72% | -$1.98M | ﹤0.01% | 2617 |
|
|
2021
Q4 | $4.83M | Sell |
30,830
-12,688
| -29% | -$2.18M | ﹤0.01% | 1240 |
|
|
2021
Q3 | $8.86M | Sell |
43,518
-14,518
| -25% | -$3.2M | ﹤0.01% | 1362 |
|
|
2021
Q2 | $12.1M | Buy |
58,036
+23,649
| +69% | +$4.33M | 0.01% | 1167 |
|
|
2021
Q1 | $6.06M | Buy |
34,387
+2,662
| +8% | +$530K | ﹤0.01% | 1250 |
|
|
2020
Q4 | $3.69M | Sell |
31,725
-46,214
| -59% | -$4.91M | ﹤0.01% | 1543 |
|
|
2020
Q3 | $8.37M | Buy |
77,939
+25,612
| +49% | +$3.12M | 0.01% | 930 |
|
|
2020
Q2 | $5.04M | Sell |
52,327
-23,570
| -31% | -$901K | ﹤0.01% | 1158 |
|
|
2020
Q1 | $1.05M | Sell |
75,897
-61,055
| -45% | -$517K | ﹤0.01% | 1679 |
|
|
2019
Q4 | $545K | Buy |
136,952
+87,554
| +177% | +$380K | ﹤0.01% | 2622 |
|
|
2019
Q3 | $248K | Buy |
49,398
+47,449
| +2,435% | +$260K | ﹤0.01% | 2781 |
|
|
2019
Q2 | $11K | Buy |
+1,949
| New | +$15.3K | ﹤0.01% | 4487 |
|
|
2019
Q1 | – | Sell |
-269
| Closed | -$10K | – | 4608 |
|
|
2018
Q4 | $10K | Buy |
269
+137
| +104% | +$5.31K | ﹤0.01% | 3889 |
|
|
2018
Q3 | $5K | Sell |
132
-3
| -2% | -$84 | ﹤0.01% | 4121 |
|
|
2018
Q2 | $4K | Buy |
+135
| New | +$4.56K | ﹤0.01% | 4184 |
|
|
2017
Q3 | – | Sell |
-15
| Closed | – | – | 4276 |
|
|
2017
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 4241 |
|
|
2017
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 4132 |
|
|
2016
Q4 | $0 | Sell |
15
-240
| -94% | -$7K | ﹤0.01% | 4144 |
|
|
2016
Q3 | $11K | Hold |
255
| – | – | ﹤0.01% | 3533 |
|
|
2016
Q2 | $37K | Sell |
255
-154
| -38% | -$17.6K | ﹤0.01% | 3159 |
|
|
2016
Q1 | $43K | Buy |
409
+148
| +57% | +$15.9K | ﹤0.01% | 3110 |
|
|
2015
Q4 | $43K | Buy |
261
+127
| +95% | +$19.5K | ﹤0.01% | 3097 |
|
|
2015
Q3 | $19K | Buy |
+134
| New | +$30K | ﹤0.01% | 3269 |
|
|
2015
Q2 | – | Sell |
-2,698
| Closed | -$446K | – | 4057 |
|
|
2015
Q1 | $446K | Buy |
+2,698
| New | +$438K | ﹤0.01% | 1998 |
|
|
2014
Q4 | – | Sell |
-20,000
| Closed | -$1.67M | – | 4122 |
|
|
2014
Q3 | $1.67M | Sell |
20,000
-237
| -1% | -$21.4K | ﹤0.01% | 1554 |
|
|
2014
Q2 | $1.87M | Buy |
+20,237
| New | +$1.78M | ﹤0.01% | 1488 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Bank of Montreal's NVAX Position: Q1 2026 in Review
Bank of Montreal increased its Novavax (NVAX) stake by 561% in Q1 2026, buying an estimated $837K and bringing the position to 108,725 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.
Bank of Montreal first reported a position in NVAX in Q2 2014 and has held it in 40 quarters since. The position peaked at $32.6M in Q3 2024. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Bank of Montreal held 108,725 shares of Novavax worth $885K as of Q1 2026.
- Bank of Montreal bought 92,288 Novavax shares in Q1 2026, an estimated $837K.
- Novavax made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2099 holding.
- Bank of Montreal first reported a position in Novavax in Q2 2014 and has held it in 40 quarters since.
- Bank of Montreal's Novavax position peaked at $32.6M in Q3 2024.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.